Roxadustat as a Hypoxia-Mimetic Agent: Erythropoietic Mechanisms, Bioanalytical Detection, and Regulatory Considerations in Sports Medicine

Roxadustat (ROX) is an orally active inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PHI) that exerts erythropoietic, cardioprotective, and metabolic regulatory effects. Approved for the treatment of anemia associated with chronic kidney disease, ROX promotes endogenous erythropoietin...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Elena-Christen Creangă, Cristina Ott, Alina-Crenguţa Nicolae, Cristina Manuela Drăgoi, Raluca Stan
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2025-09-01
סדרה:	Current Issues in Molecular Biology
נושאים:	roxadustat erythropoietin chronic kidney disease hypoxia-inducible factor prolyl hydroxylase inhibitor bioanalysis Quechers method
גישה מקוונת:	https://www.mdpi.com/1467-3045/47/9/734
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!